Balchem has defined a new five-year growth strategy on the heels of its acquisition of Kappa Bioscience and Bergstrom Nutrition, which added K2Vital and OptiMSM to its portfolio. Frederic Boned, senior vice president-general manager at Balchem, reveals how the company is “unlocking new potential” by cross-selling branded ingredients, bringing more awareness to the market and expanding internationally.
Upcoming webinars

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot
Register now

Aging Is Inevitable. Longevity Is Negotiable
Sabinsa
Register now

Texture challenges in high protein bars: Understanding the benefits of casein
Lactalis Ingredients
Register now
All upcoming webinars
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement















